Certara Reports Third Quarter 2024 Financial Results

RADNOR, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2024. Third Quarter Highlights: Revenue was $94.8 million, compared to$85.6 million in the third quarter of 2023, representing growth of 11%. Software revenue was $35.9 million, compared to$31.3 million in the third quarter of 2023, representing growth of 15%.Services revenue was $58.9 million, compared to ...